☰

IPHARMA

is a contract research organization, which specializes in the conduct of clinical drug trials in Russia, EAEU countries, Serbia, China and Australia:

  • Early phase trials
  • Pilot and registration trials
  • Bioequivalence trials
  • Post-marketing programs
  • Pharmacovigilance
Вирус

Our results from 2012 to 2025

One of the leaders in the number of clinical studies of cutting-edge Russian drugs according to ACTO data for 2013-2023.

330+
Drugs studied
310+
Protocols developed
160+
Ministry of Health permits obtained
875+
Clinical centres opened
8800+
Healthy volunteers included in studies
21000+
Patients included in studies
75+
Drugs prepared for registration
iPharma advantages

Leader in the number of clinical trials of Russian innovative drugs*

*According to the info-analytical ACTO bulletins for 2013-2023
1

Opportunities for localizing drugs, attracting investments and access to the Russian market

2

Full cycle of clinical development of drugs from first use in humans to registration

3

Medical examination with the involvement of leading Russian and foreign scientists and clinicians

4

Highly qualified specialists and quality system in accordance with international standards

5

iPharma is a member of the Chemrar and DMO group and is a partner of Skolkovo Technopark.

<p>One of the leaders in biopharmaceutical
industries in Russia</p>

One of the leaders in biopharmaceutical
industries in Russia

<p>Digital ecosystem in healthcare</p>

Digital ecosystem in healthcare

<p>assistant in the implementation of innovative projects of the largest Russian bank</p>

assistant in the implementation of innovative projects of the largest Russian bank

Calculate the cost of your research

Fill out the form and we will advise you on the timing, possibility and cost of conducting a CT. It's free.